Microfluidic devices, and methods of making and using the same

Patent metadata

Field	Value
Publication number	US-10073093-B2
Application number	US-201715703928-A
Country	US
Kind code	B2
Filing date	Sep 13, 2017
Priority date	Nov 6, 2013
Publication date	Sep 11, 2018
Grant date	Sep 11, 2018

Abstract

The present disclosure provides methods and systems for assaying a sample. A microfluidic device to perform an assay of a sample (e.g., biological sample) is described having a sample application site, a porous component and a flow channel. The porous component provides for uniform dissolution of a reagent and mixing of the sample and reagent without filtering the sample.

First claim

What is claimed is:

1. An assay method using a microfluidic device; the method comprising:
(a) providing a microfluidic device comprising:
a sample application site;
a flow channel in fluid communication with the sample application site; and
a porous component positioned between the sample application site and flow channel, wherein the porous component comprises a porous matrix comprising pores and an assay reagent comprising an analyte-specific optically detectable label positioned within the pores of the porous matrix;

(b) contacting a sample to the sample application site so that the sample flows through the porous matrix and into the flow channel, wherein the porous matrix is configured to mix the sample with the assay reagent to produce a labelled sample that then flows into the flow channel;
(c) illuminating the labelled sample in the flow channel with a light source; and
(d) detecting light from the labelled sample.

2. The method according to claim 1 , wherein the analyte-specific optically detectable label comprises an analyte-specific binding member conjugated to an optically detectable label.

3. The method according to claim 2 , wherein the analyte-specific binding member is an antibody or antibody fragment.

4. The method according to claim 3 , wherein the antibody or antibody fragment specifically binds to a target selected from the group consisting of CD14, CD4, CD45RA, CD3 and a combination thereof.

5. The method according to claim 2 , wherein the optically detectable label comprises a fluorescent dye.

6. The method according to claim 5 , wherein the fluorescent dye comprises a compound selected from the group consisting of rhodamine, coumarin, cyanine, xanthene, polymethine, pyrene, dipyrromethene borondifluoride, napthalimide, phycobiliprotein, peridinium chlorophyll proteins, conjugates thereof and a combination thereof.

7. The method according to claim 1 , wherein 95% or greater of the sample passes through the porous matrix into the flow channel.

8. The method according to claim 1 , wherein the method comprises illuminating the sample with a broad spectrum light source.

9. The method according to claim 8 , wherein the broad spectrum light source comprises an ultraviolet light source and a visible light source.

10. The method according to claim 8 , wherein the method comprises illuminating the sample with light having a wavelength between 200 nm and 800 nm.

11. The method according to claim 1 , wherein detecting light from the labelled sample comprises capturing an image of the sample in the flow channel.

12. The method according to claim 1 , wherein the sample is a biological fluid.

13. The method according to claim 12 , wherein the biological fluid is whole blood.

14. The method according to claim 12 , wherein the biological fluid is plasma.

15. The method according to claim 1 , wherein the assay reagent is positioned within the pores of the porous matrix.

16. The method according to claim 15 , wherein the assay reagent is dry.

17. The method according to claim 1 , wherein the porous matrix comprises pores having diameters between 1 μm and 200 μm.

18. An assay method using a microfluidic device; the method comprising:
contacting a sample to a sample application site of a microfluidic device, the microfluidic device comprising:
a flow channel in fluid communication with the sample application site; and
a porous component positioned between the sample application site and flow channel, wherein the porous component comprises a porous matrix and an assay reagent;

wherein the porous matrix comprises pores; wherein the assay reagent is positioned within the pores of the porous reagent; and
wherein the porous matrix is configured to mix the sample with the assay reagent to produce a labeled sample that flows into the flow channel.

19. The method according to claim 18 , wherein the assay reagent comprises an analyte-specific binding member conjugated to an optically detectable label.

20. The method according to claim 19 , wherein the analyte-specific binding member is an antibody or antibody fragment.

Assignees

• Becton Dickinson Co

Inventors

• Bornheimer Scott Joseph
• Sugarman Jeffrey
• Huang Wei
• Goldberg Edward Michael
• Tan Ming

Classifications

• B01L2400/086

  using baffles or other fixed flow obstructions · CPC title

• B01L2400/0406

  capillary forces · CPC title

• B01F2215/0431

  Numerical size values, e.g. diameter of a hole or conduit, area, volume, length, width, or ratios thereof · CPC title

• B01L3/5023

  with a sample being transported to, and subsequently stored in an absorbent for analysis · CPC title

• B01L2200/16

  Reagents, handling or storing thereof · CPC title